Dr. Mukund Chorghade is Founder, President and Chief Scientific Officer, THINQ Pharma / MVRC Research and Ayurvidya Healthcare Innovations. He is the CSO, Chicago Discovery Solutions and APINOVO. He holds or has held Adjunct Research Professor, Visiting Fellow, or Visiting Scientist appointments at Caltech, Harvard, MIT, Northeastern, Northwestern, Princeton, Rutgers, University of Chicago (USA); University of British Columbia (Canada); Cambridge, Strathclyde, (UK); College de France, Universite Louis Pasteur (France); ICT, CSIR, KHRC (India), and others. He provides synthetic chemistry and pharmaceutical development expertise to academic laboratories, pharmaceutical and biopharmaceutical companies. His research interests are in Drug Discovery and Development Process Chemistry Derived Medicinal Chemistry, Traditional Medicine derived New Chemical Entities. His discovery of sterically protected and electronically activated metalloporphyrin catalysts called “chemosynthetic livers” finds utility in drug metabolism, valorization of biomass and environmental remediation. He is also qualified as an expert in patent trials.
He earned his B.Sc. and M.Sc. degrees from the University of Poona, and a Ph.D. in organic chemistry from Georgetown University.